← Leaderboards
Timothy Rodell
Globeimmune, Inc.
$3,000,000
Attributed
$3,000,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2013–15$1M$750K$500K$250K$0
'13
'14
'15
Funding mix
By agency
NIH$3,000,000 · 1
By mechanism
R01$3,000,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Globeimmune, Inc.
Same institution · by research overlap
- Richard Chatterton Duke$1,000,000
Others in their field
Top investigators on “Animal Model Selection”
- David Heimbrook · Leidos Biomedical Research, Inc.$144,028,280
- David Allen · Integrated Laboratory Systems, Llc$41,848,911
- Ehud Isacoff · University Of California Berkeley$39,511,100
- James E Crowe · Vanderbilt University Medical Center$33,001,687
- James R Gaines · University Of Hawaii At Manoa$32,499,553
- Nelson J. Chao · Duke University$32,242,139
Research focus
Animal Model SelectionAnimalsAnti-Bacterial AgentsAntigen-Presenting CellsAntigensAntigen TargetingAreaBaseBiotechnologyBioterrorismCaviaCd4 Positive T LymphocytesCd8b1 GeneCell Mediated Immune ResponseCellsCellular ImmunityClinicClinically RelevantClinical TrialsCollaborationsColoradoCommunicable DiseasesC Type Lectin ReceptorsAdjuvant
Grant awards (3)
Recombinant yeast vaccines for sensitive and drug-resistant M. tuberculosis$1,000,000
R01 · FY2015 · AI · contact PI
Recombinant yeast vaccines for sensitive and drug-resistant M. tuberculosis$1,000,000
R01 · FY2014 · AI · contact PI
Recombinant yeast vaccines for sensitive and drug-resistant M. tuberculosis$1,000,000
R01 · FY2013 · AI · contact PI